Acta Vet. Brno 2018, 87: 127-135
https://doi.org/10.2754/avb201887020127
Matrix metalloproteinases 2 and 9 activity after intra-articular injection of autologous platelet-rich plasma for the treatment of osteoarthritis in dogs
References
1. 2006: Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthr Cartilage 14: 1272-1280
< K, An HS, Okuma M, Attawia M, Miyamoto K, Thonar EJ-MA, Lenz ME, Sah MD https://doi.org/10.1016/j.joca.2006.05.008>
2. 2004: Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 91: 4-15
< E, Andia I, Ardanza B, Nurden P, Nurden AT https://doi.org/10.1160/TH03-07-0440>
3. 2007: Systematic review of clinical trials of treatments for osteoarthritis in dogs. J Am Vet Med Assoc 230: 514-521
< CL, Hofmeister EH, Budsberg SC https://doi.org/10.2460/javma.230.4.514>
4. 2013: The basic science of platelet-rich plasma (PRP): what clinicians need to know. Sports Med Arthrosc 21: 180-185
< SP, Shebani-Rad S https://doi.org/10.1097/JSA.0b013e3182999712>
5. 2014: MMP-2 as an early synovial biomarker for cranial cruciate ligament disease in dogs. Vet Comp Orthop Traumatol 3: 210-215
< L, Danger R, Cabon Q, Rabillard M, Brouard S, Bouvy B, Gauthier O https://doi.org/10.3415/VCOT-13-06-0082>
6. 2008: Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis. J Am Vet Med Assoc 233: 1278-1283
< DC, Boston RC, Coyne JC, Farrar JT https://doi.org/10.2460/javma.233.8.1278>
7. 2007: Development and psychometric testing of an instrument designed to measure chronic pain in dogs with osteoarthritis. Am J Vet Res 68: 631-637
< DC, Boston RC, Coyne JC, Farrar JT https://doi.org/10.2460/ajvr.68.6.631>
8. 2003: Platelet-rich plasma gel promotes differentiation and regeneration during equine wound healing. Exp Mol Pathol 74: 244-255
< CA, Jolly DG, Worden Sr CE, Hendren DG, Kane CJM https://doi.org/10.1016/S0014-4800(03)00017-0>
9. 1995: Proteinases and inhibitors. Br Med Bull 51: 385-401
< T https://doi.org/10.1093/oxfordjournals.bmb.a072968>
10. 2006: Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124: 263-266
< J, Pollard JW https://doi.org/10.1016/j.cell.2006.01.007>
11. 1998: Matrix metalloproteinases 2 and 9 in canine rheumatoid arthritis. Vet Rec 143: 219-223
< AR, Robertson DH, Bennett D, May C, Beynon RJ, Carter SD https://doi.org/10.1136/vr.143.8.219>
12. 2008: Growth factor delivery methods in the management of sports injuries: the state of play. Br J Sports Med 42: 314-320
< L, Hamilton B https://doi.org/10.1136/bjsm.2007.040071>
13. 2004: Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci 30: 145-151
< G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, Moroni M, Carabelli A https://doi.org/10.1016/j.transci.2004.01.004>
14. 1989: Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 84: 678-685
< DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF https://doi.org/10.1172/JCI114215>
15. 2010: Shedding light in the controversial terminology for platelet-rich products: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet-leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism. J Biomed Mater Res A 95: 1280-1282
< Ehrenfest DM, Bielecki T, Del Corso M, Inchingolo F, Sammatino G https://doi.org/10.1002/jbm.a.32894>
16. 2013: A randomized controlled trial of the efficacy of autologous plasma rich platelet therapy for the treatment of osteoarthritis in dogs. J Am Vet Med Assoc 243: 1291-1297
< MA, Ortolano GA, Gurecio V, Schaffer JA, Johnston G, Au J, Hettlich BA, Philips T, Allen MJ, Bertone AL https://doi.org/10.2460/javma.243.9.1291>
17. Fox SM, Millis D 2010: Multimodal management of canine osteoarthritis. London: Manson Publishing Ltd, 96.
18. 2015: Characteristics of canine platelet-rich plasma prepared with five commercially available systems. Am J Vet Res 76: 822-827
< SP, Garner BC, Cook JL https://doi.org/10.2460/ajvr.76.9.822>
19. 2008: Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol 40: 1334-1347
< SE, Parks WC https://doi.org/10.1016/j.biocel.2007.10.024>
20. 2011: Reliability and validity of a visual analogue scale used by owners to measure chronic pain attributable to osteoarthritis in their dogs. Am J Vet Res 72: 601-607
< AK, Kapatkin AS, Rita HJ https://doi.org/10.2460/ajvr.72.5.601>
21. 2014: Variance of matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) concentrations in activated, concentrated platelets from healthy male donors. J Orthop Surg Res 9: 29
< JM, Evanson JL, Johnson PC, Zumbrun SD, Guyton MK, McPherson III JC, Bojerscu JA https://doi.org/10.1186/1749-799X-9-29>
22. 2004: Assessing repeatability and validity of a visual analogue scale questionnaire for use in assessing pain and lameness in dogs. Am J Vet Res 65: 1634-1643
< JT, Slater MR, Taylor L, Scott M, Kerwin SC https://doi.org/10.2460/ajvr.2004.65.1634>
23. Image J 2015 1.46 software (NIH, http://imagej.nih.gov/ij/)
24. 2004: Radiographic progression of osteoarthritis of the canine stifle joint: a prospective study. Vet Radiol Ultrasound 45: 143-148
< JF, Costello M, Barr FJ, Rudolf H, Barr ARS https://doi.org/10.1111/j.1740-8261.2004.04024.x>
25. 2003: Platelet-rich plasma-derived fibrin clot formation stimulates collagen synthesis in periodontal ligament and osteoblastic cells in vitro. J Periodontal 74: 858-864
< T, Okuda K, Wolff L, Yoshie H https://doi.org/10.1902/jop.2003.74.6.858>
26. 2004: Platelet-Rich Plasma: Evidence to Support Its Use. Int J Oral Maxillofac Surg 62: 489-496
< RE https://doi.org/10.1016/j.joms.2003.12.003>
27. 1995. Matrix metalloproteinases and their inhibitors. Acta Ortho Scandi Suppl 266: 55-60
< G https://doi.org/10.3109/17453679509157648>
28. 2002: Understanding the pathophysiology of osteoarthritis. Vet Med 97: 108-117
JK, McLaughlin RM, Radlinsky MG
29. 2012: Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil 91: 411-441
< T, Rosocha J, Lacko M, Harvanova D, Gharaibeh A https://doi.org/10.1097/PHM.0b013e3182aab72>
30. Schulz KS 2013: Degenerative Joint Disease. In; Fossum TW (Ed.): Small Animal Surgery. Fourth Edition. Elsevier, USA, pp 1226-1229
31. 2014: The Anti-inflammatory and Matrix Restorative Mechanisms of Platelet-Rich Plasma in Osteoarthritis. Am J Sports Med 42: 35-41
< EA, Cole BJ, Karas V, Valle CD, Tetreault MW, Mohammed HO, Fortier LA https://doi.org/10.1177/0363546513507766>
32. University of Pennsylvania School of Veterinary Medicine Veterinary Clinical Investigations Center 2012: Canine Brief Pain Inventory. Available at: research.vet.upenn.edu/PennChart/Available Tools/tabid/1969/Default.aspx.
33. 2011: Autologous protein solution inhibits MMP-13 production by IL-1beta and TNFalpha-stimulated human articular chondrocytes. J Orthop Res 29: 1320-1326
< J, Matuska A, Oyster M https://doi.org/10.1002/jor.21384>
34. 2013: The effect of platelet-rich plasma on patterns of gene expression in a dog model of anterior cruciate ligament reconstruction. J Surg Res 180: 80-88
< X, Wu H, Zhao S, Xie G, Huangfu X, Zhao J https://doi.org/10.1016/j.jss.2012.10.036>
35. 2004: Expression analysis of three isoforms of hyaluronan synthase and hyaluronidase in the synovium of knees in osteoarthritis and rheumatoid arthritis by quantitative real-time reverse transcriptase polymerase chain reaction. Arthritis Res Ther 6: R514-R520
< M, Sai S, Marumo K,Tanaka T, Itano N,Kimata K, Fujii K https://doi.org/10.1186/ar1223>